US Department of Defense
BLAST INJURY RESEARCH
COORDINATING OFFICE
Advancing Blast Injury Research to Protect and Heal Those Who Serve

2nd Japan-US Technical Information Exchange Forum on Blast Injury (JUFBI-2017)


Click for larger version

On April 14-16, 2017, Blast Injury Research Program Coordinating Office (PCO) Director, Mr. Leggieri, and PCO Deputy Director, Dr. Gupta, participated in the 2nd Japan-US Technical Information Exchange Forum on Blast Injury (JUFBI-2017) in Tokyo, Japan. The PCO organized this forum on behalf of the DoD Executive Agent in coordination with the National Defense Medical College of the Japan Self-Defense Forces (JSDF), and US Army Research, Development and Engineering Command (RDECOM) International Technology Center-Pacific (ITC-PAC).

Download JUFBI-2017 Announcement (PDF 122 KB)

Approximately 100 attendees participated in JUFBI-2017. US participants included representatives from the US Army Medical and Materiel Command, US Army Research Laboratory, RDECOM (ITC-PAC), New Jersey Institute of Technology, Newark, New Jersey, and the Icahn School of Medicine, Mt. Sanai, New York, New York. Japan participants included representatives from the Ministry of Defense of Japan, JSDF, and academia. This year's forum also included participants from the Royal British Legion Centre for Blast Injury Studies at the Imperial College London, United Kingdom.

The objectives of JUFBI-2017 include achieving a mutual understating of Japan/US efforts in blast injury research; identifying knowledge gaps requiring collaborative research; and increasing understanding and collaboration to improve prevention, clinical diagnosis, and treatment of brain, lung, and auditory blast injuries. In support of these objectives, presentation topics covered a wide range of blast injury issues, including traumatic brain injury, auditory injury, and wound infections. Proceedings of JUFBI-2017 are being prepared and will be posted on this website when available.

Read More about US - Japan Collaboration.

Last modified: 03-Apr-2023